Advertisement

Archives of Gynecology and Obstetrics

, Volume 300, Issue 5, pp 1303–1316 | Cite as

Clinical relevance of colonization with antimicrobial-resistant bacteria (AMRB) and methicillin susceptible Staphylococcus aureus (MSSA) for mothers during pregnancy

  • A. H. DammeyerEmail author
  • S. Heinze
  • A. C. Adler
  • L. Nasri
  • L. Schomacher
  • M. Zamfir
  • K. Heigl
  • B. Karlin
  • M. Franitza
  • S. Hörmansdorfer
  • C. Tuschak
  • G. Valenza
  • U. Ochmann
  • C. Herr
General Gynecology
  • 38 Downloads

Abstract

Purpose

The impact of colonization with antimicrobial-resistant bacteria (AMRB) and methicillin-sensitive Staphylococcus aureus (MSSA) of healthy pregnant women is not described in detail in Germany. In this study, we screened for MSSA and AMRB, especially for methicillin-resistant S. aureus (MRSA) as well as extended-spectrum beta-lactamase (ESBL)-producing E. coli. Potential risk factors for colonization with AMRB/MSSA and the potential effects of colonization with these on the obstetric population were investigated.

Methods

From October 2013 until December 2015 pregnant women were screened before birth for colonization with AMRB/MSSA from the mammillae, nose, perianal and vaginal area. Before birth, the expectant mother was administered a standardized interview questionnaire by a trained interviewer. Data from the hospital admission records were also included.

Results

Samples from 651 pregnant women were analyzed. Colonization with MSSA was detected in 14.3% (n = 93), AMRB in 3.5% [(n = 23); MRSA: n = 3/ESBL: n = 20]. Significantly more colonization of AMRB/MSSA could be detected in women who had previously given birth compared to women who were nulliparous (p < 0.05). MSSA colonization was significantly associated with self-reported respiratory diseases during pregnancy (p < 0.05), but AMRB/MSSA colonization was not statistically associated with other types of infection.

Conclusion

Our results demonstrate a low overall rate of colonization with AMRB/MSSA, as well as a low percentage of colonized pregnant women who developed infections. Multiparous women are at higher risk for colonization with MSSA/MRSA or ESBL. Because the prevalence of AMRB/MSSA is low, this study suggests that general screening of pregnant women without risk factors is not recommended.

Keywords

MRSA MSSA ESBL AMR AMRB Pregnancy Prevalence Risk factors 

Notes

Author contributions

AHD: Data Collection, Data Analysis, Manuscript writing. SH: Protocol/project development, Manuscript editing. ACA: Protocol/project development, Laboratory work, Data Collection, Manuscript editing. LN: Data Collection, Protocol development. LS: Data Collection, Protocol development. MZ: Data Collection, Data Analysis, Laboratory work, Manuscript editing. KH: Manuscript editing. BK: Protocol/project development, Data Collection. MF: Protocol/project development, Data Collection. SH: Laboratory work. CT: Laboratory work. GV: Laboratory work. UO: Protocol/project development. CH: Protocol/project development, Manuscript editing.

Funding

This study was funded by the Bavarian State Ministry of Public Health and Care Services.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants

Ethical approval was provided by the Ludwig-Maximilians-University, Munich, Germany. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent: Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    (2015) ECDC publishes 2014 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe. Eurosurveillance 20(46) (Epub 2015/11/27)Google Scholar
  2. 2.
    Geffers C, Gastmeier P (2011) Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System). Deutsches Arzteblatt International 108(6):87–93 (Epub 2011/03/05)PubMedPubMedCentralGoogle Scholar
  3. 3.
    Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339(8):520–532 (Epub 1998/08/26)CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance 13(47):19044PubMedPubMedCentralGoogle Scholar
  5. 5.
    Ruscher C. [Not Available]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2015;58(6):654. Epub 2015/05/06. Erratum zu: Empfehlungen zur Pravention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stammen (MRSA) in medizinischen und pflegerischen Einrichtungen : Empfehlung der Kommission fur Krankenhaushygiene und Infektionspravention (KRINKO) beim Robert Koch-Institu.Google Scholar
  6. 6.
    van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL et al (2009) Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 199(12):1820–1826 (Epub 2009/05/08)CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Meyer E, Gastmeier P, Kola A, Schwab F (2012) Pet animals and foreign travel are risk factors for colonisation with extended-spectrum beta-lactamase-producing Escherichia coli. Infection 40(6):685–687 (Epub 2012/09/14)CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Eckmanns T, Richter D, Feig M. [MRSA and ESBL in outpatient: development from 2008 up to 2012 and socio demographic differences]. Berliner und Munchener tierarztliche Wochenschrift. 2014;127(9–10):399–402. Epub 2015/04/15. MRSA und ESBL in der ambulanten Versorgung: Entwicklung in den Jahren 2008 bis 2012 sowie soziodemografische Unterschiede.Google Scholar
  9. 9.
    Danino D, Melamed R, Sterer B, Porat N, Hazan G, Gushanski A, et al. (2018) Mother to child transmission of extended spectrum beta-lactamase producing Enterobacteriaceae. J Hosp Infect 100:46 (Epub 2018/01/14).Google Scholar
  10. 10.
    Becker K, Schaumburg F, Fegeler C, Friedrich AW, Kock R (2017) Staphylococcus aureus from the German general population is highly diverse. Int J Med Microbiol 307(1):21–27 (Epub 2016/12/27)CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Walter J, Noll I, Feig M, Weiss B, Claus H, Werner G, et al. (2017) Decline in the proportion of methicillin resistance among Staphylococcus aureus isolates from non-invasive samples and in outpatient settings, and changes in the co-resistance profiles: an analysis of data collected within the Antimicrobial Resistance Surveillance Network, Germany 2010 to 2015. BMC Infect Dis 17(1):169 (Epub 2017/02/25).Google Scholar
  12. 12.
    Gray JW, Suviste J (2012) Three years' experience of screening for meticillin-resistant Staphylococcus aureus in obstetrics. J Hosp Infect (0).Google Scholar
  13. 13.
    Beigi RH (2011) Clinical implications of methicillin-resistant Staphylococcus aureus in pregnancy. Curr Opin Obstet Gynecol 23(2):82–86 (Epub 2010/12/24)CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Reusch M, Ghosh P, Ham C, Klotchko A, Singapuri S, Everett G (2008) Prevalence of MRSA colonization in peripartum mothers and their newborn infants. Scand J Infect Dis 40(8):667–671 (Epub 2008/11/04)CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Gray J, Patwardhan SC, Martin W (2010) Meticillin-resistant Staphylococcus aureus screening in obstetrics: a review. J Hosp Infect 75(2):89–92 (Epub 2010/04/13)CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Stenehjem E, Rimland D (2013) MRSA nasal colonization burden and risk of MRSA infection. Am J Infect Control 41(5):405–410 (Epub 2012/12/25)CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Layer F, Cuny C, Strommenger B, Werner G, Witte W. [Current data and trends on methicillin-resistant Staphylococcus aureus (MRSA)]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2012;55(11–12):1377–86. Epub 2012/11/02. Aktuelle Daten und Trends zu Methicillin-resistenten Staphylococcus aureus (MRSA).Google Scholar
  18. 18.
    Kellie. Methicillin-resistant Staphylococcus aureus (MRSA) in pregnancy: epidemiology, clinical syndromes, management, prevention, and infection control in the peripartum and post-partum periods.Google Scholar
  19. 19.
    Laibl VR, Sheffield JS, Roberts S, McIntire DD, Trevino S, Wendel GD Jr (2005) Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy. Obstet Gynecol 106(3):461–465 (Epub 2005/09/02)CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Connolly A, Thorp JM Jr (1999) Urinary tract infections in pregnancy. Urol Clin N Am 26(4):779–787 (Epub 1999/12/10)CrossRefGoogle Scholar
  21. 21.
    Zilberberg MD, Shorr AF (2013) Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000–2009. Infect Control Hosp Epidemiol 34(9):940–946 (Epub 2013/08/07)CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Saiman L, O'Keefe M, Graham PL 3rd, Wu F, Said-Salim B, Kreiswirth B et al (2003) Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 37(10):1313–1319 (Epub 2003/10/30)CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Graffunder EM, Venezia RA (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49(6):999–1005 (Epub 2002/06/01)CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Mahamat A, MacKenzie FM, Brooker K, Monnet DL, Daures JP, Gould IM (2007) Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimicrob Agents 30(2):169–176 (Epub 2007/06/15)CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Kock R, Winner K, Schaumburg F, Jurke A, Rossen JW, Friedrich AW (2014) Admission prevalence and acquisition of nasal carriage of meticillin-resistant Staphylococcus aureus (MRSA) in German rehabilitation centres. J Hosp Infect 87(2):115–118 (Epub 2014/05/06)CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Kock R, Werner P, Friedrich AW, Fegeler C, Becker K (2016) Persistence of nasal colonization with human pathogenic bacteria and associated antimicrobial resistance in the German general population. New Microbes New Infect 9:24–34 (Epub 2016/02/11)CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Eppes CS, Clark SL. Extended-spectrum beta-lactamase infections during pregnancy: a growing threat. American journal of obstetrics and gynecology. 2015. Epub 2015/03/17.Google Scholar
  28. 28.
    Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA et al (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5(12):751–762CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Herrmann M, Petit C, Dawson A, Biechele J, Halfmann A, von Muller L et al (2013) Methicillin-resistant Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence screening study. PloS One 8(9):e73876 (Epub 2013/09/17)CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Ostholm-Balkhed A, Tarnberg M, Nilsson M, Nilsson LE, Hanberger H, Hallgren A (2013) Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother 68(9):2144–2153 (Epub 2013/05/16)CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Maier J, Melzl H, Reischl U, Drubel I, Witte W, Lehn N et al (2005) Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Germany associated with travel or foreign family origin. Eur J Clin Microbiol Infect Dis 24(9):637–639 (Epub 2005/09/17)CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Niniou I, Vourli S, Lebessi E, Foustoukou M, Vatopoulos A, Pasparakis DG et al (2008) Clinical and molecular epidemiology of community-acquired, methicillin-resistant Staphylococcus aureus infections in children in central Greece. Eur J Clin Microbiol Infect Dis 27(9):831–837 (Epub 2008/06/10)CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Johansson PJ, Gustafsson EB, Ringberg H (2007) High prevalence of MRSA in household contacts. Scand J Infect Dis 39(9):764–768 (Epub 2007/08/19)CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Mohsin M, Raza S, Schaufler K, Roschanski N, Sarwar F, Semmler T, et al. High Prevalence of CTX-M-15-Type ESBL-Producing E. coli from Migratory Avian Species in Pakistan. Front Microbiol 8:2476 (Epub 2018/01/10)CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Köck R, Mellmann A, Schaumburg F, Friedrich AW, Kipp F, Becker K (2011) The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Germany. Deutsches Arzteblatt International 108(45):761–767 (Epub 2011/12/14)PubMedPubMedCentralGoogle Scholar
  36. 36.
    Cuny C, Kock R, Witte W (2013) Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany. Int J Med Microbiol 303(6–7):331–337 (Epub 2013/04/24)CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Zamfir M, Adler AC, Kolb S, Dammeyer A, Nasri L, Schomacher L et al (2017) Evaluation of sampling locations in pregnant women and newborns for the detection of colonisation with antibiotic-resistant bacteria. Eur J Clin Microbiol Infect Dis 36(10):1819–1826 (Epub 2017/05/06)CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Adler AC, Zamfir M, Hendrowarsito L, Dammeyer A, Schomacher L, Karlin B et al (2017) Hospitalization cost at childbirth: Health parameters and colonization with antimicrobial resistant bacteria and methicillin susceptible Staphylococcus aureus. Eur J Obstet Gynecol Reprod Biol 215:20–27 (Epub 2017/06/09)CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Valenza G, Nickel S, Pfeifer Y, Eller C, Krupa E, Lehner-Reindl V et al (2014) Extended-spectrum-beta-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother 58(2):1228–1230 (Epub 2013/12/04)CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    RKI. Staphylokokken-Erkrankungen, insbesondere Infektionen durch MRSA. https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Staphylokokken_MRSA.html: RKI; 2016 [cited 2019 13.01.2019].
  41. 41.
    Huang SS, Platt R (2003) Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36(3):281–285 (Epub 2003/01/23)CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18(4):657–686 (Epub 2005/10/15)CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Popp W, Kundt R, Haamann F (2010) al. e. Personalrisiko durch MRSA—ein unterschätzes Thema [Personnel risk of MRSA—an underestimated topic]. Arbeitsmed Sozialme Umweltmed 45:107–110Google Scholar
  44. 44.
    Safdar N, Bradley EA (2008) The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 121(4):310–315CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Chen KT, Campbell H, Borrell LN, Huard RC, Saiman L, Della-Latta P (2007) Predictors and outcomes for pregnant women with vaginal-rectal carriage of community-associated methicillin-resistant Staphylococcus aureus. Am J Perinatol 24(4):235–240 (Epub 2007/04/21)CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F et al (2008) Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14(1):144–153 (Epub 2007/12/25)CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Dhillon RH, Clark J (2012) ESBLs: a clear and present danger? Crit Care Res Pract 2012:625170 (Epub 2011/07/19)PubMedPubMedCentralGoogle Scholar
  48. 48.
    DGU L. Interdisziplinäre S3 Leitlinie: Epidemiologie, Diagnostik, Therapie, Präevention und Management unkomplizierter, bakterieller, ambulant erworbender Harnwegsinfektionen bei erwachsenen Patienten. https://www.awmf.org/uploads/tx_szleitlinien/043-044l_S3_Harnwegsinfektionen_2017-05.pdf: DGU; 2017 [20.01.2019]; Available from: https://www.awmf.org/uploads/tx_szleitlinien/043-044l_S3_Harnwegsinfektionen_2017-05.pdf.
  49. 49.
    Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews WW. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1996;174(5):1618–1621 (Epub 1996/05/01)CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O (1992) Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 80(2):173–177 (Epub 1992/08/01)PubMedPubMedCentralGoogle Scholar
  51. 51.
    Lietzau S, Sturmer T, Erb A, Von Baum H, Marre R, Brenner H (2004) Prevalence and determinants of nasal colonization with antibiotic-resistant Staphylococcus aureus among unselected patients attending general practitioners in Germany. Epidemiol Infect 132(4):655–662CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Boccaccio C, Verdaguer Babic V, Botto L, Cervetto MM, Cetani S, Paladino S et al (2014) Methicillin-resistant Staphylococcus aureus (MRSA) isolation in breast abscesses in a Public Maternity. Medicina 74(3):210–5 (Epub 2014/06/12. Aislamiento de Staphylococcus aureus meticilino resistente en abscesos de mama en una Maternidad Publica)PubMedPubMedCentralGoogle Scholar
  53. 53.
    Stafford I, Hernandez J, Laibl V, Sheffield J, Roberts S, Wendel G Jr (2008) Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization. Obstet Gynecol 112(3):533–537CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F (2004) Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 190(10):1730–1738 (Epub 2004/10/23)CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    von Wintersdorff CJ, Penders J, Stobberingh EE, Oude Lashof AM, Hoebe CJ, Savelkoul PH et al (2014) High rates of antimicrobial drug resistance gene acquisition after international travel. Neth Emerg Infect Dis 20(4):649–657 (Epub 2014/03/25)CrossRefGoogle Scholar
  56. 56.
    van Cleef BA, Graveland H, Haenen AP, van de Giessen AW, Heederik D, Wagenaar JA et al (2011) Persistence of livestock-associated methicillin-resistant Staphylococcus aureus in field workers after short-term occupational exposure to pigs and veal calves. J Clin Microbiol 49(3):1030–1033 (Epub 2011/01/14)CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Schofer H, Bruns R, Effendy I, Hartmann M, Jappe U, Plettenberg A et al (2011) Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranes. J German Soc Dermatol 9(11):953–967 (Epub 2011/10/27)Google Scholar
  58. 58.
    Borde JP, Kern WV (2012) Treatment of MRSA infections. Dtsch Med Wochenschr 137(49):2553–2557 (Epub 2012/11/13. Therapie von MRSA-Infektionen)CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Le Page S, Dubourg G, Baron SA, Rolain JM, Raoult D (2019) No global increase in resistance to antibiotics: a snapshot of resistance from 2001 to 2016 in Marseille, France. Eur J Clin Microbiol Infect Dis 38(2):395–407 (Epub 2018/12/06)CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Brinkmann A, Rohr AC, Frey OR, Kruger WA, Brenner T, Richter DC, et al. [S2k guidelines of the PEG on calculated parenteral initial treatment of bacterial diseases in adults : Focussed summary and supplementary information on antibiotic treatment of critically ill patients]. Der Anaesthesist. 2018;67(12):936–49. Epub 2018/12/05. S2k-Leitlinie der PEG zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen : Fokussierte Zusammenfassung und erganzende Informationen zur Antibiotikatherapie kritisch kranker Patienten.Google Scholar
  61. 61.
    Baldwin NS, Gilpin DF, Hughes CM, Kearney MP, Gardiner DA, Cardwell C et al (2009) Prevalence of methicillin-resistant Staphylococcus aureus colonization in residents and staff in nursing homes in Northern Ireland. J Am Geriatr Soc 57(4):620–626 (Epub 2009/04/28)CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Kallen MC, Natsch S, Opmeer BC, Hulscher M, Schouten JA, Prins JM et al (2019) How to measure quantitative antibiotic use in order to support antimicrobial stewardship in acute care hospitals: a retrospective observational study. Eur J Clin Microbiol Infect Dis 38(2):347–355 (Epub 2018/11/28)CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    [Hygiene measures for infection or colonization with multidrug-resistant gram-negative bacilli. Commission recommendation for hospital hygiene and infection prevention (KRINKO) at the Robert Koch Institute (RKI)]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2012;55(10):1311–54. Epub 2012/09/27. Hygienemassnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stabchen. Empfehlung der Kommission fur Kranken-haushygiene und Infektionspravention (KRINKO) beim Robert Koch-Institut (RKI).Google Scholar
  64. 64.
    Beigi RH, Bunge K, Song Y, Lee BY (2009) Epidemiologic and economic effect of methicillin-resistant Staphylococcus aureus in obstetrics. Obstet Gynecol 113(5):983–991 (Epub 2009/04/23)CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Patel RI, Kaufman HK (2011) Nasopharyngeal carriage of methicillin-resistant Staphylococcus aureus: incidence and outcomes in pregnant women. J Am Osteopat Assoc 111(6):389–395 (Epub 2011/07/21)Google Scholar
  66. 66.
    Coates T, Bax R, Coates A (2009) Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother 64(1):9–15CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Milstone AM, Song X, Coffin S, Elward A (2010) Identification and eradication of methicillin-resistant Staphylococcus aureus colonization in the Neonatal Intensive Care Unit: results of a National Survey. Infect Control Hosp Epidemiol 31(7):766–768CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Mollema FPN, Severin JA, Nouwen JL, Ott A, Verbrugh HA, Vos MC (2010) Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-up. Antimicrob Agents Chemother 54(9):4020–4025CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • A. H. Dammeyer
    • 1
    Email author
  • S. Heinze
    • 1
    • 2
  • A. C. Adler
    • 3
  • L. Nasri
    • 4
  • L. Schomacher
    • 1
  • M. Zamfir
    • 1
  • K. Heigl
    • 1
  • B. Karlin
    • 5
  • M. Franitza
    • 4
  • S. Hörmansdorfer
    • 1
  • C. Tuschak
    • 1
  • G. Valenza
    • 1
  • U. Ochmann
    • 2
  • C. Herr
    • 1
    • 2
  1. 1.Bavarian Health and Food Safety AuthorityMunich/Oberschleißheim/ErlangenGermany
  2. 2.Institute and Outpatient Clinic of Occupational, Social and Environmental MedicineClinic of the University of MunichMunichGermany
  3. 3.Bavarian State Ministry of Public Health and Care ServicesMunichGermany
  4. 4.Klinikum Augsburg, Women’s ClinicAugsburgGermany
  5. 5.Rotkreuzklinikum München, Women’s ClinicMunichGermany

Personalised recommendations